洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR2600118687】Effects of nature-based mindfulness training on depression among adults with childhood adversity: A randomised controlled trial

查看原文

立即下载

基本信息

登记号

ChiCTR2600118687

试验状态

尚未开始

药物名称

药物类型

规范名称

首次公示信息日的期

2026-02-10

临床申请受理号

靶点

适应症

Depression awith childhood adversity

试验通俗题目

Effects of nature-based mindfulness training on depression among adults with childhood adversity: A randomised controlled trial

试验专业题目

Effects of nature-based mindfulness training on depression among adults with childhood adversity: A randomised controlled trial

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

Objectives: 1. PInvestigate the effect of Nature-based Mindfulness Training (NBMT) on reducing depressive symptoms among adults with depression and adverse childhood experiences (ACE). 2.Investigate the effect of NBMT on reducing anxiety symptoms and improving quality of life among adults with depression and ACE. 3.Compare the effects of NBMT with MBCT in reducing depressive and anxiety symptoms and improving quality of life . 4.Examine adherence and rumination as potential mediators responsible for better outcomes in NBMT.

试验分类

请登录查看

试验类型

随机平行对照

试验分期

其它

随机化

The method of sampling will be stratified randomisation based on sex and psychiatric medication use to achieve demographic balance between the two arms. An experienced independent statistician will generate the randomisation sequence using computer-generated random results.

盲法

The research staff member who conducts the assessments or statistical analyses will be blinded to the group assignments.

试验项目经费来源

General Research Fund

试验范围

目标入组人数

128

实际入组人数

第一例入组时间

2026-02-16

试验终止时间

2028-02-16

是否属于一致性

入选标准

1) Aged 18 years or above 2) Screened by the Patient Health Questionnaire depression scale (PHQ-9) with at least moderate depressive symptoms (i.e. a PHQ score of 10 or above) 3) ACE histories will be collected using the Adverse Childhood Experiences—International Questionnaire (ACE-IQ) with at least one ACE；

排除标准

1) The presence of serious suicidal risk 2) Severe medical illness with a prognosis of less than 6 months to live 3) A diagnosis of antisocial, schizotypal, or borderline personality disorder; 4) A history of schizophrenia, schizoaffective disorder, bipolar disorder, substance abuse, or organic brain disorders.；

研究者信息

研究负责人姓名

请登录查看

试验机构

香港中文大學賽馬會公共衛生及基層醫療學院

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看